Status:
NOT_YET_RECRUITING
Personalized Medicine in the Elderly With Vision Impairment and Mild Cognitive Impairment
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60-75 years
Phase:
NA
Brief Summary
Globally, approximately 55 million people suffer from dementia, and 60-70% of cases are due to Alzheimer's disease (AD). Increasing scientific evidence highlights that the pathological changes underly...
Eligibility Criteria
Inclusion
- Patients aged ≥ 60 years with a diagnosis of aMCI
- Signing of informed consent
Exclusion
- Age \<60 years
- History of dementia
- Diabetes mellitus
- Uncontrolled hypertension
- Diagnosis of major depression
- Glaucoma
- Age-related macular degeneration
- Media opacity and vitreoretinal pathologies that may preclude a correct evaluation
- • Failure to obtain informed consent
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06942728
Start Date
May 1 2025
End Date
February 28 2027
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS, Polo Nazionale Ipovisione
Rome, Lazio, Italy, 00168